Home Cart 0 Sign in  
X

[ CAS No. 629-94-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 629-94-7
Chemical Structure| 629-94-7
Chemical Structure| 629-94-7
Structure of 629-94-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 629-94-7 ]

Related Doc. of [ 629-94-7 ]

Alternatived Products of [ 629-94-7 ]

Product Details of [ 629-94-7 ]

CAS No. :629-94-7 MDL No. :MFCD00009346
Formula : C21H44 Boiling Point : -
Linear Structure Formula :- InChI Key :FNAZRRHPUDJQCJ-UHFFFAOYSA-N
M.W : 296.57 Pubchem ID :12403
Synonyms :
Chemical Name :n-Heneicosane

Calculated chemistry of [ 629-94-7 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 18
Num. H-bond acceptors : 0.0
Num. H-bond donors : 0.0
Molar Refractivity : 103.06
TPSA : 0.0 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -0.31 cm/s

Lipophilicity

Log Po/w (iLOGP) : 5.85
Log Po/w (XLOGP3) : 10.99
Log Po/w (WLOGP) : 8.44
Log Po/w (MLOGP) : 7.6
Log Po/w (SILICOS-IT) : 8.43
Consensus Log Po/w : 8.26

Druglikeness

Lipinski : 1.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -7.41
Solubility : 0.0000114 mg/ml ; 0.0000000385 mol/l
Class : Poorly soluble
Log S (Ali) : -10.96
Solubility : 0.0000000033 mg/ml ; 0.0 mol/l
Class : Insoluble
Log S (SILICOS-IT) : -8.34
Solubility : 0.00000137 mg/ml ; 0.0000000046 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.84

Safety of [ 629-94-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 629-94-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 629-94-7 ]
  • Downstream synthetic route of [ 629-94-7 ]

[ 629-94-7 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 50-32-8 ]
  • [ 85-44-9 ]
  • [ 629-62-9 ]
  • [ 16746-02-4 ]
  • [ 544-76-3 ]
  • [ 593-45-3 ]
  • [ 629-92-5 ]
  • [ 629-94-7 ]
  • [ 59914-18-0 ]
  • [ 2315-68-6 ]
  • [ 117-81-7 ]
  • [ 93-89-0 ]
  • [ 52763-11-8 ]
  • [ 20548-62-3 ]
  • [ 3351-31-3 ]
Reference: [1] Patent: US2008/242875, 2008, A1, . Location in patent: Page/Page column 9-11; 17-18
  • 2
  • [ 129-00-0 ]
  • [ 85-44-9 ]
  • [ 90-47-1 ]
  • [ 629-62-9 ]
  • [ 629-97-0 ]
  • [ 630-01-3 ]
  • [ 629-59-4 ]
  • [ 544-76-3 ]
  • [ 112-34-5 ]
  • [ 97-87-0 ]
  • [ 629-94-7 ]
  • [ 638-67-5 ]
  • [ 646-31-1 ]
  • [ 629-99-2 ]
  • [ 203-63-4 ]
  • [ 128-37-0 ]
  • [ 84-66-2 ]
  • [ 84-74-2 ]
  • [ 203-64-5 ]
  • [ 85-68-7 ]
  • [ 4371-26-0 ]
  • [ 16162-34-8 ]
  • [ 57-10-3 ]
Reference: [1] Patent: US2008/242875, 2008, A1, . Location in patent: Page/Page column 5-8; 15-16
Same Skeleton Products
Historical Records